|
1
|
Kent KC, Zwolak RM, Egorova NN, Riles TS,
Manganaro A, Moskowitz AJ, Gelijns AC and Greco G: Analysis of risk
factors for abdominal aortic aneurysm in a cohort of more than 3
million individuals. J Vasc Surg. 52:539–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michel JB, Martin-Ventura JL, Egido J,
Sakalihasan N, Treska V, Lindholt J, Allaire E, Thorsteinsdottir U
and Cockerill G: Novel aspects of the pathogenesis of aneurysms of
the abdominal aorta in humans. Cardiovasc Res. 90:18–27. 2011.
View Article : Google Scholar :
|
|
3
|
Golledge J and Kuivaniemi H: Genetics of
abdominal aortic aneurysm. Curr Opin Cardiol. 28:290–296. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim HW and Stansfield BK: Genetic and
epigenetic regulation of aortic aneurysms. Biomed Res Int.
2017:72685212017.PubMed/NCBI
|
|
5
|
Kuivaniemi H, Ryer EJ, Elmore JR and Tromp
G: Understanding the pathogenesis of abdominal aortic aneurysms.
Expert Rev Cardiovasc Ther. 13:975–987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nordon IM, Hinchliffe RJ, Loftus IM and
Thompson MM: Pathophysiology and epidemiology of abdominal aortic
aneurysms. Nat Rev Cardiol. 8:92–102. 2011. View Article : Google Scholar
|
|
7
|
Jagadesham VP, Scott DJ and Carding SR:
Abdominal aortic aneurysms: An autoimmune disease? Trends Mol Med.
14:522–529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tilson MD: Decline of the atherogenic
theory of the etiology of the abdominal aortic aneurysm and rise of
the autoimmune hypothesis. J Vasc Surg. 64:1523–1525. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beckman EN: Plasma cell infiltrates in
atherosclerotic abdominal aortic aneurysms. Am J Clin Pathol.
85:21–24. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koch AE, Haines GK, Rizzo RJ, Radosevich
JA, Pope RM, Robinson PG and Pearce WH: Human abdominal aortic
aneurysms. Immunophenotypic analysis suggesting an immune-mediated
response. Am J Pathol. 137:1199–1213. 1990.PubMed/NCBI
|
|
11
|
Cohen JR, Keegan L, Sarfati I, Danna D,
Ilardi C and Wise L: Neutrophil chemotaxis and neutrophil elastase
in the aortic wall in patients with abdominal aortic aneurysms. J
Invest Surg. 4:423–430. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimizu K, Mitchell RN and Libby P:
Inflammation and cellular immune responses in abdominal aortic
aneurysms. Arterioscler Thromb Vasc Biol. 26:987–994. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuruda T, Kato J, Hatakeyama K, Kojima K,
Yano M, Yano Y, Nakamura K, Nakamura-Uchiyama F, Matsushima Y,
Imamura T, et al: Adventitial mast cells contribute to pathogenesis
in the progression of abdominal aortic aneurysm. Circ Res.
102:1368–1377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dale MA, Ruhlman MK and Baxter BT:
Inflammatory cell phenotypes in AAAs: Their role and potential as
targets for therapy. Arterioscler Thromb Vasc Biol. 35:1746–1755.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L and Wang Y: B lymphocytes in
abdominal aortic aneurysms. Atherosclerosis. 242:311–317. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rizas KD, Ippagunta N and Tilson MD III:
Immune cells and molecular mediators in the pathogenesis of the
abdominal aortic aneurysm. Cardiol Rev. 17:201–210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Latz E, Xiao TS and Stutz A: Activation
and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kono H, Kimura Y and Latz E: Inflammasome
activation in response to dead cells and their metabolites. Curr
Opin Immunol. 30:91–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo H, Callaway JB and Ting JP:
Inflammasomes: Mechanism of action, role in disease, and
therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vasanthakumar A and Kallies A: Interleukin
(IL)-33 and the IL-1 family of cytokines-regulators of inflammation
and tissue homeostasis. Cold Spring Harb Perspect Biol.
11:a0285062019. View Article : Google Scholar
|
|
21
|
Yazdi AS, Drexler SK and Tschopp J: The
role of the inflamma-some in nonmyeloid cells. J Clin Immunol.
30:623–627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei-Leston AC, Murphy AG and Maloy KJ:
Epithelial cell inflammasomes in intestinal immunity and
inflammation. Front Immunol. 8:11682017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dihlmann S, Erhart P, Mehrabi A,
Nickkholgh A, Lasitschka F, Bockler D and Hakimi M: Increased
expression and activation of absent in melanoma 2 inflammasome
components in lympho-cytic infiltrates of abdominal aortic
aneurysms. Mol Med. 20:230–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barnard GA: A new test for 2×2 tables.
Nature. 156:1771945. View
Article : Google Scholar
|
|
25
|
Erhart P, Grond-Ginsbach C, Hakimi M,
Lasitschka F, Dihlmann S, Bockler D and Hyhlik-Dürr A: Finite
element analysis of abdominal aortic aneurysms: Predicted rupture
risk correlates with aortic wall histology in individual patients.
J Endovasc Ther. 21:556–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Erhart P, Schiele S, Ginsbach P,
Grond-Ginsbach C, Hakimi M, Bockler D, Lorenzo-Bermejo J and
Dihlmann S: Gene expression profiling in abdominal aortic aneurysms
after finite element rupture risk assessment. J Endovasc Ther.
24:861–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Bai S, Ao Q, Wang X, Tian X, Li X,
Tong H, Hou W and Fan J: Modulation of Immune-Inflammatory
responses in abdominal aortic aneurysm: Emerging molecular targets.
J Immunol Res. 2018:72137602018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Deroide N and Mallat Z: The role of
the inflammasome in cardiovascular diseases. J Mol Med (Berl).
92:307–319. 2014. View Article : Google Scholar
|
|
29
|
Usui F, Shirasuna K, Kimura H, Tatsumi K,
Kawashima A, Karasawa T, Yoshimura K, Aoki H, Tsutsui H, Noda T, et
al: Inflammasome activation by mitochondrial oxidative stress in
macrophages leads to the development of angiotensin II-induced
aortic aneurysm. Arterioscler Thromb Vasc Biol. 35:127–136. 2015.
View Article : Google Scholar
|
|
30
|
Bobryshev YV and Lord RS:
Vascular-associated lymphoid tissue (VALT) involvement in aortic
aneurysm. Atherosclerosis. 154:15–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ocana E, Bohorquez JC, Perez-Requena J,
Brieva JA and Rodriguez C: Characterisation of T and B lymphocytes
infiltrating abdominal aortic aneurysms. Atherosclerosis.
170:39–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Johnston WF, Salmon M, Su G, Lu G, Stone
ML, Zhao Y, Owens GK, Upchurch GR Jr and Ailawadi G: Genetic and
pharmacologic disruption of interleukin-1β signaling inhibits
experimental aortic aneurysm formation. Arterioscler Thromb Vasc
Biol. 33:294–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Isoda K, Akita K, Kitamura K,
Sato-Okabayashi Y, Kadoguchi T, Isobe S, Ohtomo F, Sano M, Shimada
K, Iwakura Y and Daida H: Inhibition of interleukin-1 suppresses
angiotensin II-induced aortic inflammation and aneurysm formation.
Int J Cardiol. 270:221–227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ridker PM, Thuren T, Zalewski A and Libby
P: Interleukin-1β inhibition and the prevention of recurrent
cardiovascular events: Rationale and design of the canakinumab
anti-inflammatory thrombosis outcomes study (CANTOS). Am Heart J.
162:597–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shah SR, Abbasi Z, Fatima M, Ochani RK,
Shahnawaz W, Asim Khan M and Shah SA: Canakinumab and
cardiovascular outcomes: Results of the CANTOS trial. J Community
Hosp Intern Med Perspect. 8:21–22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Weber C and von Hundelshausen P: CANTOS
trial validates the inflammatory pathogenesis of Atherosclerosis:
Setting the stage for a new chapter in therapeutic targeting. Circ
Res. 121:1119–1121. 2017. View Article : Google Scholar : PubMed/NCBI
|
